What is sufficient evidence for the reliability and validity of patient-reported outcome measures?

被引:381
|
作者
Frost, Marlene H.
Reeve, Bryce B.
Liepa, Astra M.
Stauffer, Joseph W.
Hays, Ron D.
Sloan, Jeff A.
机构
[1] Mayo Clin, Womens Canc Program, Rochester, MN USA
[2] NCI, Div Canc Control & Populat Sci, Outcomes Res Branch, Appl Res Program, Bethesda, MD 20892 USA
[3] Eli Lilly & Co, Global Hlth Outcomes, Indianapolis, IN 46285 USA
[4] Alpharma, Global Med Affairs, Piscataway, NJ USA
[5] Univ Calif Los Angeles, Dept Hlth Sci, Dept Med, UCLA Div Gen Internal Med & Hlth Ser Res, Los Angeles, CA USA
[6] RAND Corp, Santa Monica, CA USA
关键词
patient-reported outcomes; psychometric; validation;
D O I
10.1111/j.1524-4733.2007.00272.x
中图分类号
F [经济];
学科分类号
02 ;
摘要
This article focuses on the necessary psychometric properties of a patient-reported outcomes (PROs) measure. Topics include the importance of reliability and validity, psychometric approaches used to provide reliability and validity estimates, the kinds of evidence needed to indicate that a PRO has a sufficient level of reliability and validity, contexts that may affect psychometric properties, methods available to evaluate PRO instruments when the context varies, and types of reliability and validity testing that are appropriate during different phases of clinical trials. Points discussed include the perspective that the psychometric properties of reliability and validity are on a continuum in which the more evidence one has, the greater confidence there is in the value of the PRO data. Construct validity is the type of validity most frequently used with PRO instruments as few "gold standards" exist to allow the use of criterion validity and content validity by itself only provides beginning evidence of validity. Several guidelines are recommended for establishing sufficient evidence of reliability and validity. For clinical trials, a minimum reliability threshold of 0.70 is recommended. Sample sizes for testing should include at least 200 cases and results should be replicated in at least one additional sample. At least one full report on the development of the instrument and one on the use of the instrument are deemed necessary to evaluate the PRO psychometric properties. Psychometric testing ideally occurs before the initiation of Phase III trials. When testing does not occur prior to a Phase III trial, considerable risk is posed in relation to the ability to substantiate the use of the PRO data. Various qualitative (e.g., focus groups, behavioral coding, cognitive interviews) and quantitative approaches (e.g., differential item functioning testing) are useful in evaluating the reliability and validity of PRO instruments.
引用
收藏
页码:S94 / S105
页数:12
相关论文
共 50 条
  • [31] Patient-reported outcome measures for allergy and asthma in children
    Soyiri, Ireneous N.
    Nwaru, Bright I.
    Sheikh, Aziz
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2016, 27 (08) : 779 - 783
  • [32] Patient-Reported Outcome Measures in Breast Cancer Surgery
    Kim, Minji
    Graziano, Francis D.
    Tadros, Audree B.
    Allen Jr, Robert J.
    Nelson, Jonas A.
    CURRENT SURGERY REPORTS, 2024, 12 (05) : 67 - 75
  • [33] Correlation of PROMIS with Orthopaedic Patient-Reported Outcome Measures
    Cheung, Edward C.
    Moore, Laura K.
    Flores, Sergio E.
    Lansdown, Drew A.
    Feeley, Brian T.
    Zhang, Alan L.
    JBJS REVIEWS, 2019, 7 (08)
  • [34] An introduction to patient-reported outcome measures (PROMs) in physiotherapy
    Kyte, D. G.
    Calvert, M.
    van der Wees, P. J.
    ten Hove, R.
    Tolan, S.
    Hill, J. C.
    PHYSIOTHERAPY, 2015, 101 (02) : 119 - 125
  • [35] Patient-reported Outcome Measures for Angioedema: A Literature Review
    Brix, Anna Trier Heiberg
    Boysen, Henrik Balle
    Weller, Karsten
    Caballero, Teresa
    Bygum, Anette
    ACTA DERMATO-VENEREOLOGICA, 2021, 101
  • [36] Patient-Reported Outcome Measures A Resource for Recreational Therapists
    McCormick, Bryan P.
    Austin, David R.
    THERAPEUTIC RECREATION JOURNAL, 2021, 55 (01) : 97 - 106
  • [37] Patient-Reported Outcome Measures in Dermatology: A Systematic Review
    Pattinson, Rachael L.
    Trialonis-Suthakharan, Nirohshah
    Gupta, Sunnia
    Henry, Alasdair L.
    Lavallee, Jacqueline F.
    Otten, Marina
    Pickles, Timothy
    Courtier, Nick
    Austin, Jennifer
    Janus, Christine
    Augustin, Matthias
    Bundy, Chris
    ACTA DERMATO-VENEREOLOGICA, 2021, 101
  • [38] Patient-Reported Outcome Measures in Systemic Sclerosis (Scleroderma)
    Pellar, Russell E.
    Tingey, Theresa M.
    Pope, Janet Elizabeth
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2016, 42 (02) : 301 - +
  • [39] Patient-reported outcome measures for asthma: a systematic review
    Worth, Allison
    Hammersley, Victoria
    Knibb, Rebecca
    Flokstra-de-Blok, Bertine
    DunnGalvin, Audrey
    Walker, Samantha
    Dubois, Anthony E. J.
    Sheikh, Aziz
    NPJ PRIMARY CARE RESPIRATORY MEDICINE, 2014, 24
  • [40] Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis
    Sari, Fulden
    Apaydin, Zilan Bazancir
    Apaydin, Hakan
    Kayaalp, Mehmet
    Erden, Abdulsamet
    Guven, Serdar Can
    Armagan, Berkan
    Omma, Ahmet
    Kucuksahin, Orhan
    Erten, Sukran
    ARCHIVES OF RHEUMATOLOGY, 2024, 39 (01) : 52 - 59